Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env

被引:17
作者
Ensoli, B
Cafaro, A
Caputo, A
Fiorelli, V
Ensoli, F
Gavioli, R
Ferrantelli, F
Cara, A
Titti, F
Magnani, M
机构
[1] Ist Super Sanita, AIDS Natl Ctr, I-00161 Rome, Italy
[2] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35122 Padua, Italy
[3] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
[4] Univ Urbino, Inst Biol Chem G Fornaini, I-61029 Urbino, Italy
关键词
Tat protein; Delta V2 Env protein; HIV/AIDS vaccine;
D O I
10.1016/j.micinf.2005.07.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The promising results obtained with the HIV-1 Tat-based vaccines in mice, monkeys and humans, a better understanding of Tat immunomodulatory functions, as well as evidence that vaccination with trimeric V2 loop-deleted HIV-1 Env induces cross-clade neutralizing antibodies led to the rational design of a novel vaccine based on the combination of Tat and V2-deleted Env. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:1392 / 1399
页数:8
相关论文
共 18 条
[1]  
Ando K, 1997, J IMMUNOL, V158, P5283
[2]  
BARILLARI G, 1992, J IMMUNOL, V149, P3727
[3]  
BARNETT SW, 2005, IN PRESS MICROBES IN
[4]   Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans [J].
Buttò, S ;
Fiorelli, V ;
Tripiciano, A ;
Ruiz-Alvarez, MJ ;
Scoglio, A ;
Ensoli, F ;
Ciccozzi, M ;
Collacchi, B ;
Sabbatucci, M ;
Cafaro, A ;
Guzmán, CA ;
Borsetti, A ;
Caputo, A ;
Vardas, E ;
Colvin, M ;
Lukwiya, M ;
Rezza, G ;
Ensoli, B .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (08) :1171-1180
[5]   Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine [J].
Cafaro, A ;
Caputo, A ;
Fracasso, C ;
Maggiorella, MT ;
Goletti, D ;
Baroncelli, S ;
Pace, M ;
Sernicola, L ;
Koanga-Mogtomo, ML ;
Betti, M ;
Borsetti, A ;
Belli, R ;
Åkerblom, L ;
Corrias, F ;
Buttò, S ;
Heeney, J ;
Verani, P ;
Titti, F ;
Ensoli, B .
NATURE MEDICINE, 1999, 5 (06) :643-650
[6]   Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) [J].
Cafaro, A ;
Titti, F ;
Fracasso, C ;
Maggiorella, MT ;
Baroncelli, S ;
Caputo, A ;
Goletti, D ;
Borsetti, A ;
Pace, M ;
Fanales-Belasio, E ;
Ridolfi, B ;
Negri, DRM ;
Sernicola, L ;
Belli, R ;
Corrias, F ;
Macchia, I ;
Leone, P ;
Michelini, Z ;
ten Haaft, P ;
Buttò, S ;
Verani, P ;
Ensoli, B .
VACCINE, 2001, 19 (20-22) :2862-2877
[7]   SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine [J].
Cafaro, A ;
Caputo, A ;
Maggiorella, MT ;
Baroncelli, S ;
Fracasso, C ;
Pace, M ;
Borsetti, A ;
Sernicola, L ;
Negri, DRM ;
Ten Haaft, P ;
Betti, M ;
Michelini, Z ;
Macchia, I ;
Fanales-Belasio, E ;
Belli, R ;
Corrias, F ;
Buttò, S ;
Verani, P ;
Titti, F ;
Ensoli, B .
JOURNAL OF MEDICAL PRIMATOLOGY, 2000, 29 (3-4) :193-208
[8]   Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA [J].
Cara, A ;
Vargas, J ;
Keller, M ;
Jones, S ;
Mosoian, A ;
Gurtman, A ;
Cohen, A ;
Parkas, V ;
Wallach, F ;
Chusid, E ;
Gelman, IH ;
Klotman, ME .
VIROLOGY, 2002, 292 (01) :1-5
[9]   Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA [J].
Cara, A ;
Maggiorella, MT ;
Bona, R ;
Sernicola, L ;
Baroncelli, S ;
Negri, DRM ;
Leone, P ;
Fagrouch, Z ;
Heeney, J ;
Titti, F ;
Cafaro, A ;
Ensoli, B .
VIROLOGY, 2004, 324 (02) :531-539
[10]   HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region [J].
Chang, HC ;
Samaniego, F ;
Nair, BC ;
Buonaguro, L ;
Ensoli, B .
AIDS, 1997, 11 (12) :1421-1431